Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Oct 5:13:247.
doi: 10.1186/1471-244X-13-247.

Magnetic resonance imaging of a randomized controlled trial investigating predictors of recovery following psychological treatment in adolescents with moderate to severe unipolar depression: study protocol for Magnetic Resonance-Improving Mood with Psychoanalytic and Cognitive Therapies (MR-IMPACT)

Cindy C Hagan  1 , Julia Me Graham, Barry Widmer, Rosemary J Holt, Cinly Ooi, Adrienne O van Nieuwenhuizen, Peter Fonagy, Shirley Reynolds, Mary Target, Raphael Kelvin, Paul O Wilkinson, Edward T Bullmore, Belinda R Lennox, Barbara J Sahakian, Ian Goodyer, John Suckling
Affiliations
Randomized Controlled Trial

Magnetic resonance imaging of a randomized controlled trial investigating predictors of recovery following psychological treatment in adolescents with moderate to severe unipolar depression: study protocol for Magnetic Resonance-Improving Mood with Psychoanalytic and Cognitive Therapies (MR-IMPACT)

Cindy C Hagan et al. BMC Psychiatry. .

Abstract

Background: Major depressive disorders (MDD) are a debilitating and pervasive group of mental illnesses afflicting many millions of people resulting in the loss of 110 million working days and more than 2,500 suicides per annum. Adolescent MDD patients attending NHS clinics show high rates of recurrence into adult life. A meta-analysis of recent research shows that psychological treatments are not as efficacious as previously thought. Modest treatment outcomes of approximately 65% of cases responding suggest that aetiological and clinical heterogeneity may hamper the better use of existing therapies and discovery of more effective treatments. Information with respect to optimal treatment choice for individuals is lacking, with no validated biomarkers to aid therapeutic decision-making.

Methods/design: Magnetic resonance-Improving Mood with Psychoanalytic and Cognitive Therapies, the MR-IMPACT study, plans to identify brain regions implicated in the pathophysiology of depressions and examine whether there are specific behavioural or neural markers predicting remission and/or subsequent relapse in a subsample of depressed adolescents recruited to the IMPACT randomised controlled trial (Registration # ISRCTN83033550).

Discussion: MR-IMPACT is an investigative biomarker component of the IMPACT pragmatic effectiveness trial. The aim of this investigation is to identify neural markers and regional indicators of the pathophysiology of and treatment response for MDD in adolescents. We anticipate that these data may enable more targeted treatment delivery by identifying those patients who may be optimal candidates for therapeutic response.

Trial registration: Adjunctive study to IMPACT trial (Current Controlled Trials: ISRCTN83033550).

PubMed Disclaimer

Figures

Figure 1
Figure 1
The relation of the IMPACT trial to the MR-IMPACT study.
See this image and copyright information in PMC

References

    1. World Health Organization. The global burden of disease: 2004 update. Switzerland: World Health Organization; 2008.
    1. Fombonne E, Wostear G, Cooper V, Harrington R, Rutter M. The Maudsley long-term follow-up of child and adolescent depression 1: psychiatric outcomes in adulthood. Br J Psychiatry. 2001;179:210–217. doi: 10.1192/bjp.179.3.210. - DOI - PubMed
    1. Fombonne E, Wostear G, Cooper V, Harrington R, Rutter M. The Maudsley long-term follow-up of child and adolescent depression 2: suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry. 2001;179:218–223. doi: 10.1192/bjp.179.3.218. - DOI - PubMed
    1. Harrington R, Clark A. Prevention and early intervention for depression in adolescence and early adult life. Eur Arch Psychiatry Clin Neurosci. 1998;248:32–45. doi: 10.1007/s004060050015. - DOI - PubMed
    1. Kuyken W, Dalgleish T. Overgeneral autobiographical memory in adolescents at risk for depression. Memory. 2011;19:241–250. doi: 10.1080/09658211.2011.554421. - DOI - PubMed

Publication types

Associated data